"Amphotericin B" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela.
Descriptor ID |
D000666
|
MeSH Number(s) |
D02.540.576.500.500
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Amphotericin B".
Below are MeSH descriptors whose meaning is more specific than "Amphotericin B".
This graph shows the total number of publications written about "Amphotericin B" by people in this website by year, and whether "Amphotericin B" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 0 | 1 | 1 |
2000 | 1 | 0 | 1 |
2001 | 1 | 0 | 1 |
2002 | 1 | 3 | 4 |
2003 | 1 | 1 | 2 |
2004 | 1 | 1 | 2 |
2005 | 1 | 0 | 1 |
2009 | 0 | 1 | 1 |
2010 | 1 | 0 | 1 |
2011 | 1 | 3 | 4 |
2013 | 0 | 3 | 3 |
2015 | 0 | 1 | 1 |
2017 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Amphotericin B" by people in Profiles.
-
Sharma AI, Olson CL, Mamede JI, Gazos-Lopes F, Epting CL, Almeida IC, Engman DM. Sterol targeting drugs reveal life cycle stage-specific differences in trypanosome lipid rafts. Sci Rep. 2017 08 22; 7(1):9105.
-
Le T, Kinh NV, Cuc NTK, Tung NLN, Lam NT, Thuy PTT, Cuong DD, Phuc PTH, Vinh VH, Hanh DTH, Tam VV, Thanh NT, Thuy TP, Hang NT, Long HB, Nhan HT, Wertheim HFL, Merson L, Shikuma C, Day JN, Chau NVV, Farrar J, Thwaites G, Wolbers M. A Trial of Itraconazole or Amphotericin B for HIV-Associated Talaromycosis. N Engl J Med. 2017 06 15; 376(24):2329-2340.
-
Fernandes C, Prados-Rosales R, Silva BM, Nakouzi-Naranjo A, Zuzarte M, Chatterjee S, Stark RE, Casadevall A, Gon?alves T. Activation of Melanin Synthesis in Alternaria infectoria by Antifungal Drugs. Antimicrob Agents Chemother. 2015 Dec 28; 60(3):1646-55.
-
Srinivasan A, Gupta CM, Agrawal CM, Leung KP, Lopez-Ribot JL, Ramasubramanian AK. Drug susceptibility of matrix-encapsulated Candida albicans nano-biofilms. Biotechnol Bioeng. 2014 Feb; 111(2):418-24.
-
Jha RK, Sah AK, Shah DK, Sah P. The treatment of visceral leishmaniasis: safety and efficacy. JNMA J Nepal Med Assoc. 2013 Oct-Dec; 52(192):645-51.
-
Siles SA, Srinivasan A, Pierce CG, Lopez-Ribot JL, Ramasubramanian AK. High-throughput screening of a collection of known pharmacologically active small compounds for identification of Candida albicans biofilm inhibitors. Antimicrob Agents Chemother. 2013 Aug; 57(8):3681-7.
-
Kim MS, Lee HM, Sung HS, Won CH, Chang SE, Lee MW, Choi JH, Moon KC. Breakthrough disseminated fusariosis in an immunocompromised patient on voriconazole therapy. Int J Dermatol. 2012 May; 51(5):621-3.
-
Martins M, Henriques M, Lopez-Ribot JL, Oliveira R. Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms. Mycoses. 2012 Jan; 55(1):80-5.
-
Uppuluri P, Srinivasan A, Ramasubramanian A, Lopez-Ribot JL. Effects of fluconazole, amphotericin B, and caspofungin on Candida albicans biofilms under conditions of flow and on biofilm dispersion. Antimicrob Agents Chemother. 2011 Jul; 55(7):3591-3.
-
Srinivasan A, Uppuluri P, Lopez-Ribot J, Ramasubramanian AK. Development of a high-throughput Candida albicans biofilm chip. PLoS One. 2011 Apr 22; 6(4):e19036.